Stock Market Today, June 4: Broadcom Drags on Nasdaq at Midday

Broadcom fell around 15% after a disappointing AI-chip outlook, triggering profit-taking across semiconductors and weighing on the Nasdaq, which slipped 0.39%. The S&P 500 was little changed, up 0.17%, as strength in healthcare and value/energy names offset chip weakness, while the Dow rose 1.69%. The move highlights heightened investor sensitivity to AI valuations and sector rotation after a very strong semiconductor run.

Analysis

The immediate read-through is not “AI is broken,” but that the market is repricing the durability of second-derivative capex beneficiaries versus the durability of end-demand. When one of the highest-quality AI hardware franchises lowers the probability of a smooth spending ramp, the first-order hit is to the complex, but the bigger effect is on multiples: investors begin to discount slower revenue conversion across the entire semiconductor stack. That typically creates a 3-10 trading day de-rating window, even if the underlying buildout story remains intact.

The relative winners are less about generic defensives and more about names where earnings revisions can stay positive despite a factor rotation. Healthcare leadership here matters because it gives portfolio managers a place to hide without abandoning growth outright; that tends to pull capital from crowded AI winners into “quality at a reasonable price” and makes the rotation self-reinforcing. The second-order loser is not just AVGO/MU/AMD, but the whole equipment-and-infrastructure ecosystem that trades on forward capacity expansion rather than current utilization.

The market may be overreacting if it extrapolates one guidance reset into a capex peak. The more important question is whether hyperscaler budgets are slowing or simply shifting toward a smaller set of model winners; if the latter, returns on AI hardware become more concentrated, not eliminated. Over months, the dispersion trade matters more than the outright short: companies with pricing power, diversified exposure, or non-AI revenue can outperform even if the broad chip basket lags.

Near term, the risk is that crowded positioning forces mechanical selling and vol spikes before fundamentals stabilize. A reversal catalyst would be any reassurance from the next major cloud or GPU demand datapoint that demand is intact but timing has shifted; absent that, the sector can stay under pressure for several weeks as estimates get haircut and sentiment resets.

Key Decisions for Investors

• Short AVGO vs long XLV for 2-4 weeks: express a factor-rotation view rather than a blanket market short; target continued multiple compression in semis with healthcare as a cleaner destination.
• Fade the first bounce in AMD and MU via short-dated call spreads or put spreads into strength over the next 5-10 trading days; the setup is more about estimate revisions than one-day price action.
• Avoid adding to NVDA until the market gets a confirming data point from hyperscaler capex commentary; if you must own AI, prefer the highest-quality beneficiary with the strongest balance sheet and end-demand visibility.
• For tactical hedging, buy a semis basket put spread against existing tech exposure for 1-2 months; risk/reward is attractive if the de-rating wave extends beyond the initial gap-down.
• If NVCR strength persists, treat it as a signal that capital is rotating to under-owned healthcare beta; consider a small long basket in profitable healthcare names as a hedge against further AI factor unwind.